EICHOR
● Active Not Recruiting
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Condition: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) · Sponsor: Hoffmann-La Roche
About this study
The main objective of this study is to evaluate the efficacy of satralizumab compared with placebo based on time from randomization to the first occurrence of an adjudicated MOGAD relapse in the double-blind (DB) treatment period. Participants who experience an adjudicated relapse or complete the DB period can enter open-label extension (OLE) period. After the primary clinical cutoff date (CCOD), additional adolescent participants may be enrolled directly into the OLE period.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (53)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| University of California Irvine - Manchester Pavilion | Irvine, California, United States | — |
| University of Colorado - Anschutz Medical Campus (University of Colorado Health Sciences Center) | Aurora, Colorado, United States | — |
| Medstar Georgetown University Hospital | Washington D.C., District of Columbia, United States | — |
| University of Florida College of Medicine Gainesville | Gainesville, Florida, United States | — |
| Johns Hopkins | Baltimore, Maryland, United States | — |
| Massachusetts General Hospital | Boston, Massachusetts, United States | — |
| Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis | Owosso, Michigan, United States | — |
| Mayo Clinic - Rochester | Rochester, Minnesota, United States | — |
| Washington University School of Medicine in St. Louis | St Louis, Missouri, United States | — |
| NYU Langone | New York, New York, United States | — |
| University of Cincinnati | Cincinnati, Ohio, United States | — |
+ 41 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05271409